Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Crystal Structure of the Extracellular Segment of Integrin V3 in Complex with an Arg-Gly-Asp Ligand
Jian-Ping Xiong,1Thilo Stehle,12*Rongguang Zhang,3*Andrzej Joachimiak,3Matthias Frech,4Simon L. Goodman,5M. Amin Arnaout1
The structural basis for the divalent
cation-dependent binding of heterodimeric integrins to their
ligands, which containthe prototypical Arg-Gly-Asp sequence, is
unknown. Interactionwith ligands triggers tertiary and quaternary
structural rearrangementsin integrins that are needed for cell
signaling. Here we reportthe crystal structure of the extracellular
segment of integrinV3 in complex with a cyclic peptide
presenting the Arg-Gly-Aspsequence. The ligand binds at the major
interface between theV and 3 subunits and makes extensive
contacts with both. Bothtertiary and quaternary changes are observed
in the presence ofligand. The tertiary rearrangements take place in
A, the ligand-bindingdomain of 3; in the complex, A acquires
two cations, one ofwhich contacts the ligand Asp directly and the
other stabilizesthe ligand-binding surface. Ligand binding induces
small changesin the orientation of V relative to 3.
1 Renal Unit, Leukocyte Biology and
Inflammation Program, Structural Biology Program, Massachusetts General
Hospital, 149 13th Street, Charlestown, MA 02129, USA.
2 Laboratory of Developmental Immunology,
Massachusetts General Hospital, and Harvard Medical School, 55 Fruit
Street, Boston, MA 02114, USA.
3 Argonne National
Laboratory, Biosciences Division, Structural Biology Center, IL 60439, USA.
4 Department of Target Research,
5 Biomedical Research, Oncology, Merck KGaA,
Darmstadt 64271, Germany.
*
These two authors contributed equally to this work.
To whom correspondence should be addressed. E-mail:
arnaout{at}receptor.mgh.harvard.edu
The editors suggest the following Related Resources on Science sites:
The Unique Disulfide Bond-stabilized W1 {beta}4-{beta}1 Loop in the {alpha}4 {beta}-Propeller Domain Regulates Integrin {alpha}4{beta}7 Affinity and Signaling.
J. Yue, Y. Pan, L. Sun, K. Zhang, J. Liu, L. Lu, and J. Chen (2013)
J. Biol. Chem.
288, 14228-14237
|Abstract »|Full Text »|PDF »
Integrin {alpha}IIb{beta}3: From Discovery to Efficacious Therapeutic Target.
Structural and Functional Analysis of Coxsackievirus A9 Integrin {alpha}v{beta}6 Binding and Uncoating.
S. Shakeel, J. J. T. Seitsonen, T. Kajander, P. Laurinmaki, T. Hyypia, P. Susi, and S. J. Butcher (2013)
J. Virol.
87, 3943-3951
|Abstract »|Full Text »|PDF »
In Vitro Activity of the {alpha}v{beta}3 Integrin Antagonist RGDechi-hCit on Malignant Melanoma Cells.
M. PISANO, I. DE PAOLA, V. NIEDDU, I. SASSU, S. COSSU, G. GALLERI, A. DEL GATTO, M. BUDRONI, A. COSSU, M. SAVIANO, et al. (2013)
Anticancer Res
33, 871-879
|Abstract »|Full Text »|PDF »
Integrins {alpha}v{beta}3 and {alpha}4{beta}1 Act as Coreceptors for Fractalkine, and the Integrin-Binding Defective Mutant of Fractalkine Is an Antagonist of CX3CR1.
Conserved Fiber-Penton Base Interaction Revealed by Nearly Atomic Resolution Cryo-Electron Microscopy of the Structure of Adenovirus Provides Insight into Receptor Interaction.
C. Cao, X. Dong, X. Wu, B. Wen, G. Ji, L. Cheng, and H. Liu (2012)
J. Virol.
86, 12322-12329
|Abstract »|Full Text »|PDF »
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results.
C. SCARINGI, G. MINNITI, P. CAPORELLO, and R. M. ENRICI (2012)
Anticancer Res
32, 4213-4223
|Abstract »|Full Text »|PDF »
The RGD finger of Del-1 is a unique structural feature critical for integrin binding.
T. Schurpf, Q. Chen, J.-h. Liu, R. Wang, T. A. Springer, and J.-h. Wang (2012)
FASEB J
26, 3412-3420
|Abstract »|Full Text »|PDF »
Polydom/SVEP1 Is a Ligand for Integrin {alpha}9{beta}1.
R. Sato-Nishiuchi, I. Nakano, A. Ozawa, Y. Sato, M. Takeichi, D. Kiyozumi, K. Yamazaki, T. Yasunaga, S. Futaki, and K. Sekiguchi (2012)
J. Biol. Chem.
287, 25615-25630
|Abstract »|Full Text »|PDF »
Extra-domain B in Oncofetal Fibronectin Structurally Promotes Fibrillar Head-to-tail Dimerization of Extracellular Matrix Protein.
A. Schiefner, M. Gebauer, and A. Skerra (2012)
J. Biol. Chem.
287, 17578-17588
|Abstract »|Full Text »|PDF »
Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation.
C. T. Lefort, J. Rossaint, M. Moser, B. G. Petrich, A. Zarbock, S. J. Monkley, D. R. Critchley, M. H. Ginsberg, R. Fassler, and K. Ley (2012)
Blood
119, 4275-4282
|Abstract »|Full Text »|PDF »
Matched rabbit monoclonal antibodies against {alpha}v-series integrins reveal a novel {alpha}v{beta}3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.
Crystal structure of {alpha}5{beta}1 integrin ectodomain: Atomic details of the fibronectin receptor.
M. Nagae, S. Re, E. Mihara, T. Nogi, Y. Sugita, and J. Takagi (2012)
J. Cell Biol.
197, 131-140
|Abstract »|Full Text »|PDF »
Structure of Protein Having Inhibitory Disintegrin and Leukotriene Scavenging Functions Contained in Single Domain.
X. Xu, I. M. B. Francischetti, R. Lai, J. M. C. Ribeiro, and J. F. Andersen (2012)
J. Biol. Chem.
287, 10967-10976
|Abstract »|Full Text »|PDF »
GARP regulates the bioavailability and activation of TGF{beta}.
R. Wang, J. Zhu, X. Dong, M. Shi, C. Lu, and T. A. Springer (2012)
Mol. Biol. Cell
23, 1129-1139
|Abstract »|Full Text »|PDF »
Interleukin 32 (IL-32) Contains a Typical {alpha}-Helix Bundle Structure That Resembles Focal Adhesion Targeting Region of Focal Adhesion Kinase-1.
B. Heinhuis, M. I. Koenders, W. B. van den Berg, M. G. Netea, C. A. Dinarello, and L. A. B. Joosten (2012)
J. Biol. Chem.
287, 5733-5743
|Abstract »|Full Text »|PDF »
Extracellular Membrane-proximal Domain of HAb18G/CD147 Binds to Metal Ion-dependent Adhesion Site (MIDAS) Motif of Integrin {beta}1 to Modulate Malignant Properties of Hepatoma Cells.
Y. Li, J. Wu, F. Song, J. Tang, S.-J. Wang, X.-L. Yu, Z.-N. Chen, and J.-L. Jiang (2012)
J. Biol. Chem.
287, 4759-4772
|Abstract »|Full Text »|PDF »
The KGD Motif of Epstein-Barr Virus gH/gL Is Bifunctional, Orchestrating Infection of B Cells and Epithelial Cells.
J. Chen, C. L. Rowe, T. S. Jardetzky, and R. Longnecker (2012)
mBio
3, e00290-11
|Abstract »|Full Text »|PDF »
Stable Coordination of the Inhibitory Ca2+ Ion at the Metal Ion-Dependent Adhesion Site in Integrin CD11b/CD18 by an Antibody-Derived Ligand Aspartate: Implications for Integrin Regulation and Structure-Based Drug Design.
B. Mahalingam, K. Ajroud, J. L. Alonso, S. Anand, B. D. Adair, A. L. Horenstein, F. Malavasi, J.-P. Xiong, and M. A. Arnaout (2011)
J. Immunol.
187, 6393-6401
|Abstract »|Full Text »|PDF »
Identification of Integrin {beta} Subunit Mutations That Alter Affinity for Extracellular Matrix Ligand.
T. Kendall, L. Mukai, A. L. Jannuzi, and T. A. Bunch (2011)
J. Biol. Chem.
286, 30981-30993
|Abstract »|Full Text »|PDF »
Cilengitide induces autophagy-mediated cell death in glioma cells.
S. L. Lomonaco, S. Finniss, C. Xiang, H. K. Lee, W. Jiang, N. Lemke, S. A. Rempel, T. Mikkelsen, and C. Brodie (2011)
Neuro Oncology
13, 857-865
|Abstract »|Full Text »|PDF »
Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking.
S. Tiwari, J. A. Askari, M. J. Humphries, and N. J. Bulleid (2011)
J. Cell Sci.
124, 1672-1680
|Abstract »|Full Text »|PDF »
Proteomic Analysis of Integrin Adhesion Complexes.
A. Byron, J. D. Humphries, M. D. Bass, D. Knight, and M. J. Humphries (2011)
Science Signaling
4, pt2
|Abstract »|Full Text »|PDF »
A Review of VEGF/VEGFR-Targeted Therapeutics for Recurrent Glioblastoma.
D. A. Reardon, S. Turner, K. B. Peters, A. Desjardins, S. Gururangan, J. H. Sampson, R. E. McLendon, J. E. Herndon II, L. W. Jones, J. P. Kirkpatrick, et al. (2011)
J Natl Compr Canc Netw
9, 414-427
|Abstract »|Full Text »|PDF »
Integrin Structure, Activation, and Interactions.
I. D. Campbell and M. J. Humphries (2011)
Cold Spring Harb Perspect Biol
3, a004994
|Abstract »|Full Text »|PDF »
Tests of Integrin Transmembrane Domain Homo-oligomerization during Integrin Ligand Binding and Signaling.
W. Wang, J. Zhu, T. A. Springer, and B.-H. Luo (2011)
J. Biol. Chem.
286, 1860-1867
|Abstract »|Full Text »|PDF »
Cation-{pi} interaction regulates ligand-binding affinity and signaling of integrin {alpha}4{beta}7.
Y. Pan, K. Zhang, J. Qi, J. Yue, T. A. Springer, and J. Chen (2010)
PNAS
107, 21388-21393
|Abstract »|Full Text »|PDF »
Structural Requirements for Activation in {alpha}IIb{beta}3 Integrin.
T. Kamata, M. Handa, S. Ito, Y. Sato, T. Ohtani, Y. Kawai, Y. Ikeda, and S. Aiso (2010)
J. Biol. Chem.
285, 38428-38437
|Abstract »|Full Text »|PDF »
Closed headpiece of integrin {alpha}IIb{beta}3 and its complex with an {alpha}IIb{beta}3-specific antagonist that does not induce opening.
J. Zhu, J. Zhu, A. Negri, D. Provasi, M. Filizola, B. S. Coller, and T. A. Springer (2010)
Blood
116, 5050-5059
|Abstract »|Full Text »|PDF »
Focal adhesions in osteoneogenesis.
M. J. P. Biggs and M. J. Dalby (2010)
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine
224, 1441-1453
|Abstract »|PDF »
Direct Binding of the EGF-like Domain of Neuregulin-1 to Integrins ({alpha}v{beta}3 and {alpha}6{beta}4) Is Involved in Neuregulin-1/ErbB Signaling.
K. Ieguchi, M. Fujita, Z. Ma, P. Davari, Y. Taniguchi, K. Sekiguchi, B. Wang, Y. K. Takada, and Y. Takada (2010)
J. Biol. Chem.
285, 31388-31398
|Abstract »|Full Text »|PDF »
The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity {alpha}v{beta}3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle.
W. Xiao, Y. Wang, E. Y. Lau, J. Luo, N. Yao, C. Shi, L. Meza, H. Tseng, Y. Maeda, P. Kumaresan, et al. (2010)
Mol. Cancer Ther.
9, 2714-2723
|Abstract »|Full Text »|PDF »
Interaction of {alpha}V{beta}3 and {alpha}V{beta}6 Integrins with Human Parechovirus 1.
J. Seitsonen, P. Susi, O. Heikkila, R. S. Sinkovits, P. Laurinmaki, T. Hyypia, and S. J. Butcher (2010)
J. Virol.
84, 8509-8519
|Abstract »|Full Text »|PDF »
Requirement of open headpiece conformation for activation of leukocyte integrin {alpha}X{beta}2.
X. Chen, C. Xie, N. Nishida, Z. Li, T. Walz, and T. A. Springer (2010)
PNAS
107, 14727-14732
|Abstract »|Full Text »|PDF »
Effects of Limiting Extension at the {alpha}IIb Genu on Ligand Binding to Integrin {alpha}IIb{beta}3.
R. Blue, J. Li, J. Steinberger, M. Murcia, M. Filizola, and B. S. Coller (2010)
J. Biol. Chem.
285, 17604-17613
|Abstract »|Full Text »|PDF »
Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes.
E. J. Park, A. Peixoto, Y. Imai, A. Goodarzi, G. Cheng, C. V. Carman, U. H. von Andrian, and M. Shimaoka (2010)
Blood
115, 1572-1581
|Abstract »|Full Text »|PDF »
A Monoclonal Antibody Against {alpha}V{beta}3 Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs.
L. A. Maile, W. H. Busby, T. C. Nichols, D. A. Bellinger, E. P. Merricks, M. Rowland, U. Veluvolu, and D. R. Clemmons (2010)
Science Translational Medicine
2, 18ra11
|Abstract »|Full Text »|PDF »
Binding Investigation of Integrin {alpha}v{beta}3 With Its Inhibitors by SPR Technology and Molecular Docking Simulation.
Recreation of the terminal events in physiological integrin activation.
F. Ye, G. Hu, D. Taylor, B. Ratnikov, A. A. Bobkov, M. A. McLean, S. G. Sligar, K. A. Taylor, and M. H. Ginsberg (2010)
J. Cell Biol.
188, 157-173
|Abstract »|Full Text »|PDF »
Three-dimensional Model of Human Platelet Integrin {alpha}IIb{beta}3 in Solution Obtained by Small Angle Neutron Scattering.
A. Nogales, C. Garcia, J. Perez, P. Callow, T. A. Ezquerra, and J. Gonzalez-Rodriguez (2010)
J. Biol. Chem.
285, 1023-1031
|Abstract »|Full Text »|PDF »
Integrin Activation Dynamics between the RGD-binding Site and the Headpiece Hinge.
Plumieribetin, a Fish Lectin Homologous to Mannose-binding B-type Lectins, Inhibits the Collagen-binding {alpha}1{beta}1 Integrin.
K. de Santana Evangelista, F. Andrich, F. Figueiredo de Rezende, S. Niland, M. N. Cordeiro, T. Horlacher, R. Castelli, A. Schmidt-Hederich, P. H. Seeberger, E. F. Sanchez, et al. (2009)
J. Biol. Chem.
284, 34747-34759
|Abstract »|Full Text »|PDF »
New PI(4,5)P2- and membrane proximal integrin-binding motifs in the talin head control {beta}3-integrin clustering.
F. Saltel, E. Mortier, V. P. Hytonen, M.-C. Jacquier, P. Zimmermann, V. Vogel, W. Liu, and B. Wehrle-Haller (2009)
J. Cell Biol.
187, 715-731
|Abstract »|Full Text »|PDF »
Anti-integrin monoclonal antibodies.
A. Byron, J. D. Humphries, J. A. Askari, S. E. Craig, A. P. Mould, and M. J. Humphries (2009)
J. Cell Sci.
122, 4009-4011
|Full Text »|PDF »
Cryo-Electron Microscopy Structure of an Adenovirus-Integrin Complex Indicates Conformational Changes in both Penton Base and Integrin.
S. Lindert, M. Silvestry, T.-M. Mullen, G. R. Nemerow, and P. L. Stewart (2009)
J. Virol.
83, 11491-11501
|Abstract »|Full Text »|PDF »
The Direct Binding of Insulin-like Growth Factor-1 (IGF-1) to Integrin {alpha}v{beta}3 Is Involved in IGF-1 Signaling.
J. Saegusa, S. Yamaji, K. Ieguchi, C.-Y. Wu, K. S. Lam, F.-T. Liu, Y. K. Takada, and Y. Takada (2009)
J. Biol. Chem.
284, 24106-24114
|Abstract »|Full Text »|PDF »
Control of extracellular matrix assembly along tissue boundaries via Integrin and Eph/Ephrin signaling.
D. Julich, A. P. Mould, E. Koper, and S. A. Holley (2009)
Development
136, 2913-2921
|Abstract »|Full Text »|PDF »
Crystal structure of the complete integrin {alpha}V{beta}3 ectodomain plus an {alpha}/{beta} transmembrane fragment.
J.-P. Xiong, B. Mahalingham, J. L. Alonso, L. A. Borrelli, X. Rui, S. Anand, B. T. Hyman, T. Rysiok, D. Muller-Pompalla, S. L. Goodman, et al. (2009)
J. Cell Biol.
186, 589-600
|Abstract »|Full Text »|PDF »
Crystal Structure of the LG1-3 Region of the Laminin {alpha}2 Chain.
F. Carafoli, N. J. Clout, and E. Hohenester (2009)
J. Biol. Chem.
284, 22786-22792
|Abstract »|Full Text »|PDF »
Imaging of {alpha}v{beta}3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with {alpha}v{beta}5.
A. Zannetti, S. Del Vecchio, F. Iommelli, A. Del Gatto, S. De Luca, L. Zaccaro, A. Papaccioli, J. Sommella, M. Panico, A. Speranza, et al. (2009)
Clin. Cancer Res.
15, 5224-5233
|Abstract »|Full Text »|PDF »
The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.
K. Tan, M. Duquette, A. Joachimiak, and J. Lawler (2009)
FASEB J
23, 2490-2501
|Abstract »|Full Text »|PDF »
The Novel S527F Mutation in the Integrin {beta}3 Chain Induces a High Affinity {alpha}IIb{beta}3 Receptor by Hindering Adoption of the Bent Conformation.
K. Vanhoorelbeke, S. F. De Meyer, I. Pareyn, C. Melchior, S. Plancon, C. Margue, O. Pradier, P. Fondu, N. Kieffer, T. A. Springer, et al. (2009)
J. Biol. Chem.
284, 14914-14920
|Abstract »|Full Text »|PDF »
Molecular Basis of the Recognition of Nephronectin by Integrin {alpha}8{beta}1.
Y. Sato, T. Uemura, K. Morimitsu, R. Sato-Nishiuchi, R.-i. Manabe, J. Takagi, M. Yamada, and K. Sekiguchi (2009)
J. Biol. Chem.
284, 14524-14536
|Abstract »|Full Text »|PDF »
Real-time Analysis of Conformation-sensitive Antibody Binding Provides New Insights into Integrin Conformational Regulation.
A. Chigaev, A. Waller, O. Amit, L. Halip, C. G. Bologa, and L. A. Sklar (2009)
J. Biol. Chem.
284, 14337-14346
|Abstract »|Full Text »|PDF »
An N-Glycosylation Site on the{beta}-Propeller Domain of the Integrin {alpha}5 Subunit Plays Key Roles in Both Its Function and Site-specific Modification by{beta}1,4-N-Acetylglucosaminyltransferase III.
Y. Sato, T. Isaji, M. Tajiri, S. Yoshida-Yamamoto, T. Yoshinaka, T. Somehara, T. Fukuda, Y. Wada, and J. Gu (2009)
J. Biol. Chem.
284, 11873-11881
|Abstract »|Full Text »|PDF »
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration.
G. F. Elphick, P. P. Sarangi, Y.-M. Hyun, J. A. Hollenbaugh, A. Ayala, W. L. Biffl, H.-L. Chung, A. R. Rezaie, J. L. McGrath, D. J. Topham, et al. (2009)
Blood
113, 4078-4085
|Abstract »|Full Text »|PDF »
The C-terminal Region of Laminin {beta} Chains Modulates the Integrin Binding Affinities of Laminins.
Y. Taniguchi, H. Ido, N. Sanzen, M. Hayashi, R. Sato-Nishiuchi, S. Futaki, and K. Sekiguchi (2009)
J. Biol. Chem.
284, 7820-7831
|Abstract »|Full Text »|PDF »
Integrin {alpha}v{beta}3 on human endothelial cells binds von Willebrand factor strings under fluid shear stress.
J. Huang, R. Roth, J. E. Heuser, and J. E. Sadler (2009)
Blood
113, 1589-1597
|Abstract »|Full Text »|PDF »
Rationally Designed Integrin {beta}3 Mutants Stabilized in the High Affinity Conformation.
B.-H. Luo, J. Karanicolas, L. D. Harmacek, D. Baker, and T. A. Springer (2009)
J. Biol. Chem.
284, 3917-3924
|Abstract »|Full Text »|PDF »
Species differences in small molecule binding to {alpha}IIb{beta}3 are the result of sequence differences in 2 loops of the {alpha}IIb {beta} propeller.
R. B. Basani, H. Zhu, M. A. Thornton, C. S. Soto, W. F. DeGrado, M. A. Kowalska, J. S. Bennett, and M. Poncz (2009)
Blood
113, 902-910
|Abstract »|Full Text »|PDF »
Linking integrin conformation to function.
J. A. Askari, P. A. Buckley, A. P. Mould, and M. J. Humphries (2009)
J. Cell Sci.
122, 165-170
|Abstract »|Full Text »|PDF »
J. Liu, P. B. Gurpur, and S. J. Kaufman (2008)
J. Biol. Chem.
283, 35668-35678
|Abstract »|Full Text »|PDF »
Distinct Roles of {beta}1 Metal Ion-dependent Adhesion Site (MIDAS), Adjacent to MIDAS (ADMIDAS), and Ligand-associated Metal-binding Site (LIMBS) Cation-binding Sites in Ligand Recognition by Integrin {alpha}2{beta}1.
D. Valdramidou, M. J. Humphries, and A. P. Mould (2008)
J. Biol. Chem.
283, 32704-32714
|Abstract »|Full Text »|PDF »
Evolution of Snake Venom Disintegrins by Positive Darwinian Selection.
P. Juarez, I. Comas, F. Gonzalez-Candelas, and J. J. Calvete (2008)
Mol. Biol. Evol.
25, 2391-2407
|Abstract »|Full Text »|PDF »
The GPIIb/IIIa (integrin {alpha}IIb{beta}3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
H. P. Eikesdal, H. Sugimoto, G. Birrane, Y. Maeshima, V. G. Cooke, M. Kieran, and R. Kalluri (2008)
PNAS
105, 15040-15045
|Abstract »|Full Text »|PDF »
Pro-inflammatory Secretory Phospholipase A2 Type IIA Binds to Integrins {alpha}v{beta}3 and {alpha}4{beta}1 and Induces Proliferation of Monocytic Cells in an Integrin-dependent Manner.
J. Saegusa, N. Akakura, C.-Y. Wu, C. Hoogland, Z. Ma, K. S. Lam, F.-T. Liu, Y. K. Takada, and Y. Takada (2008)
J. Biol. Chem.
283, 26107-26115
|Abstract »|Full Text »|PDF »
Urokinase-type Plasminogen Activator Receptor Induces Conformational Changes in the Integrin {alpha}M{beta}2 Headpiece and Reorientation of Its Transmembrane Domains.
M.-L. Tang, A. Vararattanavech, and S.-M. Tan (2008)
J. Biol. Chem.
283, 25392-25403
|Abstract »|Full Text »|PDF »
Structural basis for distinctive recognition of fibrinogen {gamma}C peptide by the platelet integrin {alpha}IIb{beta}3.
Structural Basis for the Interaction of isoDGR with the RGD-binding Site of {alpha}v{beta}3 Integrin.
A. Spitaleri, S. Mari, F. Curnis, C. Traversari, R. Longhi, C. Bordignon, A. Corti, G.-P. Rizzardi, and G. Musco (2008)
J. Biol. Chem.
283, 19757-19768
|Abstract »|Full Text »|PDF »
Multimodality Molecular Imaging of Tumor Angiogenesis.
The Membrane-Spanning Domain of CD98 Heavy Chain Promotes {alpha}v{beta}3 Integrin Signals in Human Extravillous Trophoblasts.
M. Kabir-Salmani, M. N. Fukuda, M. Kanai-Azuma, N. Ahmed, S. Shiokawa, Y. Akimoto, K. Sakai, S. Nagamori, Y. Kanai, K. Sugihara, et al. (2008)
Mol. Endocrinol.
22, 707-715
|Abstract »|Full Text »|PDF »
Cell Adhesion Mechanisms in Platelets.
D. Varga-Szabo, I. Pleines, and B. Nieswandt (2008)
Arterioscler Thromb Vasc Biol
28, 403-412
|Abstract »|Full Text »|PDF »
Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium Study PBTC-012.
T. J. MacDonald, C. F. Stewart, M. Kocak, S. Goldman, R. G. Ellenbogen, P. Phillips, D. Lafond, T. Y. Poussaint, M. W. Kieran, J. M. Boyett, et al. (2008)
J. Clin. Oncol.
26, 919-924
|Abstract »|Full Text »|PDF »
Role of the {beta}-Subunit Arginine/Lysine Finger in Integrin Heterodimer Formation and Function.
V. Gupta, J. L. Alonso, T. Sugimori, M. Issafi, J.-P. Xiong, and M. A. Arnaout (2008)
J. Immunol.
180, 1713-1718
|Abstract »|Full Text »|PDF »
Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA.
J. A. Peterson, T. N. Nelson, A. J. Kanack, and R. H. Aster (2008)
Blood
111, 1234-1239
|Abstract »|Full Text »|PDF »
Application of high-throughput screening to identify a novel {alpha}IIb-specific small- molecule inhibitor of {alpha}IIb{beta}3-mediated platelet interaction with fibrinogen.
R. Blue, M. Murcia, C. Karan, M. Jirouskova, and B. S. Coller (2008)
Blood
111, 1248-1256
|Abstract »|Full Text »|PDF »
The Role of the Fibronectin IGD Motif in Stimulating Fibroblast Migration.
C. J. Millard, I. R. Ellis, A. R. Pickford, A. M. Schor, S. L. Schor, and I. D. Campbell (2007)
J. Biol. Chem.
282, 35530-35535
|Abstract »|Full Text »|PDF »
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature.
W. Cai, K. Chen, Z.-B. Li, S. S. Gambhir, and X. Chen (2007)
J. Nucl. Med.
48, 1862-1870
|Abstract »|Full Text »|PDF »
{alpha}vbeta5 Integrin Sustains Growth of Human Pre-B Cells through an RGD-independent Interaction with a Basic Domain of the CD23 Protein.
G. Borland, A. L. Edkins, M. Acharya, J. Matheson, L. J. White, J. M. Allen, J.-Y. Bonnefoy, B. W. Ozanne, and W. Cushley (2007)
J. Biol. Chem.
282, 27315-27326
|Abstract »|Full Text »|PDF »
Specific and covalent labeling of a membrane protein with organic fluorochromes and quantum dots.
R. Bonasio, C. V. Carman, E. Kim, P. T. Sage, K. R. Love, T. R. Mempel, T. A. Springer, and U. H. von Andrian (2007)
PNAS
104, 14753-14758
|Abstract »|Full Text »|PDF »
Modulation of ADP-Induced Platelet Activation by Aspirin and Pravastatin: Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Nitric Oxide, Oxidative Stress, and Inside-Out Integrin Signaling.
M. R. Marwali, C.-P. Hu, B. Mohandas, A. Dandapat, P. Deonikar, J. Chen, I. Cawich, T. Sawamura, M. Kavdia, and J. L. Mehta (2007)
J. Pharmacol. Exp. Ther.
322, 1324-1332
|Abstract »|Full Text »|PDF »
An Integrin-Tetraspanin Interaction Required for Cellular Innate Immune Responses of an Insect, Manduca sexta.
S. Zhuang, L. Kelo, J. B. Nardi, and M. R. Kanost (2007)
J. Biol. Chem.
282, 22563-22572
|Abstract »|Full Text »|PDF »
Mutation of a Conserved Asparagine in the I-like Domain Promotes Constitutively Active Integrins {alpha}Lbeta2 and {alpha}IIbbeta3.
M. Cheng, S.-Y. Foo, M.-L. Shi, R.-H. Tang, L.-S. Kong, S. K. A. Law, and S.-M. Tan (2007)
J. Biol. Chem.
282, 18225-18232
|Abstract »|Full Text »|PDF »
Ligand density dramatically affects integrin {alpha}IIb{beta}3-mediated platelet signaling and spreading.
M. Jirouskova, J. K. Jaiswal, and B. S. Coller (2007)
Blood
109, 5260-5269
|Abstract »|Full Text »|PDF »
Mapping early conformational changes in {alpha}IIb and {beta}3 during biogenesis reveals a potential mechanism for {alpha}IIb{beta}3 adopting its bent conformation.
W. Beau Mitchell, J. Li, M. Murcia, N. Valentin, P. J. Newman, and B. S. Coller (2007)
Blood
109, 3725-3732
|Abstract »|Full Text »|PDF »
The {beta}-tail domain ({beta}TD) regulates physiologic ligand binding to integrin CD11b/CD18.
V. Gupta, A. Gylling, J. L. Alonso, T. Sugimori, P. Ianakiev, J.-P. Xiong, and M. Amin Arnaout (2007)
Blood
109, 3513-3520
|Abstract »|Full Text »|PDF »